Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Andrews, Laurie
TIPI, NCT04453293: Immunization With BCG Vaccine to Prevent Tuberculosis Infection	Recruiting	3	2000	US	BCG (Tokyo 172) vaccine, Placebo, sodium glutamate	Henry M. Jackson Foundation for the Advancement of Military Medicine, United States Department of Defense, Uniformed Services University of the Health Sciences	Tuberculosis Infection	09/27	09/27
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25